Inspire Medical Systems (INSP) Cash from Investing Activities (2017 - 2026)

Inspire Medical Systems has disclosed Cash from Investing Activities across 10 years of filings, most recently posting $3.5 million for Q2 2026.

• In Q2 2026, Cash from Investing Activities fell 92.38% year-over-year to $3.5 million; the TTM figure through Jun 2026 stood at -$31.3 million (up 42.32% YoY), while the FY2025 annual figure was $21.4 million, up 118.96% from the prior year.
• Cash from Investing Activities came in at $3.5 million for Q2 2026 at Inspire Medical Systems, up from -$11.2 million in the prior quarter.
• In the past five years, Cash from Investing Activities ranged from a high of $46.6 million in Q2 2025 to a low of -$151.7 million in Q4 2023.
• Average Cash from Investing Activities over 5 years is -$23.0 million, with a median of -$3.8 million recorded in 2022.
• Year-over-year, Cash from Investing Activities tumbled 5043.15% in 2023 and jumped 728.51% in 2025.
• Over 5 years, Cash from Investing Activities stood at -$2.9 million in 2022, then plunged by 5043.15% to -$151.7 million in 2023, then surged by 102.48% to $3.8 million in 2024, then sank by 416.88% to -$11.9 million in 2025, then soared by 129.77% to $3.5 million in 2026.
• Per Business Quant data, the three most recent Cash from Investing Activities figures were $3.5 million in Q2 2026, -$11.2 million in Q1 2026, and -$11.9 million in Q4 2025.